These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8816514)

  • 1. Dysplastic nodules: a new term for premalignant hepatic nodular lesions.
    Wu TT; Boitnott J
    Radiology; 1996 Oct; 201(1):21-2. PubMed ID: 8816514
    [No Abstract]   [Full Text] [Related]  

  • 2. [Macronodules, dysplastic nodules and cirrhosis].
    Cochand-Priollet B; Fabre M
    J Radiol; 2001 Mar; 82(3 Pt 1):215-9. PubMed ID: 11287851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of the liver. Cirrhosis and premalignant nodules.
    Ohtomo K
    Magn Reson Imaging Clin N Am; 1997 May; 5(2):331-46. PubMed ID: 9113678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplastic nodules in liver cirrhosis: imaging.
    Lim JH; Choi BI
    Abdom Imaging; 2002; 27(2):117-28. PubMed ID: 11847571
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nodular hepatocellular lesions. Guidelines and minimal diagnostic criteria for gastrointestinal histopathological diagnosis. Gruppo Italiano Patologi dell'Apparato Digerente].
    Roncalli M; David E; Gentile A; Pollice L
    Pathologica; 2000 Jun; 92(3):210-20. PubMed ID: 10902435
    [No Abstract]   [Full Text] [Related]  

  • 6. Should hepatic dysplastic nodules and regenerative nodules be regarded as premalignant lesions and treated?
    Zhao L; Wong LL; Shi X; Ji J
    Hepatology; 2016 Oct; 64(4):1370. PubMed ID: 26754160
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver cirrhosis as precancerous conditions].
    Caselmann WH; Spengler U; Fischer HP; Sauerbruch T
    Internist (Berl); 1997 Oct; 38(10):928-36. PubMed ID: 9432500
    [No Abstract]   [Full Text] [Related]  

  • 8. Cirrhosis and pre-neoplastic lesions.
    Grazioli L; Olivetti L; Orlando E
    Abdom Imaging; 2012 Apr; 37(2):188-214. PubMed ID: 22297506
    [No Abstract]   [Full Text] [Related]  

  • 9. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic precancerous lesions and small hepatocellular carcinoma.
    Hytiroglou P; Park YN; Krinsky G; Theise ND
    Gastroenterol Clin North Am; 2007 Dec; 36(4):867-87, vii. PubMed ID: 17996795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
    Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
    Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometric characteristics of hepatocellular dysplasia.
    Matturri L; Bauer D
    Anal Quant Cytol Histol; 1988 Oct; 10(5):339-42. PubMed ID: 3207457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplasia in atypical liver nodes.
    Berman JJ; Moore GW
    Hum Pathol; 1996 Feb; 27(2):211-3. PubMed ID: 8617468
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study.
    Seki S; Sakaguchi H; Kitada T; Tamori A; Takeda T; Kawada N; Habu D; Nakatani K; Nishiguchi S; Shiomi S
    Clin Cancer Res; 2000 Sep; 6(9):3469-73. PubMed ID: 10999730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of liver tumors--what is necessary for therapy planning?].
    Hinterthaner M; Müller A; Ulrich A; Decker P; Hirner A; Layer G
    Zentralbl Chir; 1998; 123(2):104-10. PubMed ID: 9556880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.
    Sun M; Eshleman JR; Ferrell LD; Jacobs G; Sudilovsky EC; Tuthill R; Hussein MR; Sudilovsky O
    Hepatology; 2001 Jun; 33(6):1415-24. PubMed ID: 11391530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.
    Hussain SM; Zondervan PE; IJzermans JN; Schalm SW; de Man RA; Krestin GP
    Radiographics; 2002; 22(5):1023-36; discussion 1037-9. PubMed ID: 12235331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dysplastic nodules and precancerous lesions of liver cancer].
    Xia F; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):481-482. PubMed ID: 31357770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large cell dysplasia of hepatocytes, is it a premalignant condition?
    Kovács L; Elek G
    Acta Morphol Hung; 1987; 35(1-2):47-57. PubMed ID: 3124508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade siderotic dysplastic nodules: determination of premalignant lesions on the basis of vasculature phenotype.
    Krinsky GA; Zivin SB; Thorner KM; Lee VS; Theise ND; Weinreb JC
    Acad Radiol; 2002 Mar; 9(3):336-41. PubMed ID: 11887948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.